Company News in the Life Science Industry

»

Reset 

resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  resTORbio, Inc.

BioCryst to Report Second Quarter 2019 Financial Results on August 6

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  BioCryst Pharmaceuticals, Inc.

Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Cytokinetics, Inc.

Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum Depression

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Marinus Pharmaceuticals, Inc.

Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Myovant Sciences, Inc.

Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Idera Pharmaceuticals Inc.

VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Vivus, Inc.

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Aptose Biosciences Inc.

Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Neuronetics, Inc.

Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Opiant Pharmaceuticals, Inc.

Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Syapse, Inc.

Vericel to Report Second-Quarter 2019 Financial Results on August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Vericel Corporation

Reflect Scientific Letter from the CEO

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019

Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Kintai Therapeutics

Alimera Sciences Announces Multiple Papers “On Demand” at the 2019 American Society of Retina Specialists Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Alimera Sciences, Inc.

Spring Bank Announces Dosing of Inarigivir 400mg In Multiple HBV Studies

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Spring Bank Pharmaceuticals, Inc.

Golden Leaf Holdings Announces Meeting of Debenture Holders

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019

Diffusion Pharmaceuticals Reports Favorable Safety Data for Dose-Escalation Run-in of Phase 3 INTACT Study in Glioblastoma Multiforme Patients

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Diffusion Pharmaceuticals Inc.

Obalon Enters Into Commercial Lease for its First Company-Owned Retail Weight Loss Center

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Obalon Therapeutics Inc.

Ultragenyx to Host Conference Call for Second Quarter 2019 Financial Results and Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Ultragenyx Pharmaceutical Inc.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies